Polen Capital released its fourth-quarter investor letter for the Polen 5Perspectives Small Growth Strategy. The portfolio returned -1.3% gross and -1.5% net of fees in Q4, compared to the Russell 2000 Growth Index’s 1.2% return. Small caps finished the year with a 1.2% return, with biotech as a notable performer. The Strategy increased its Biotech exposure due to rising interest rates, M&A, and AI tailwinds. The name changed to emphasize the 5 viewpoints framework. Argan, Inc. (AGX), a construction company specializing in power plants, saw a 21.82% one-month return and has a market cap of $6.128 billion.

In the investor letter, Polen 5Perspectives Small Growth Strategy highlighted Argan, Inc. (AGX) as a company benefitting from constructing power plants for AI data centers. Argan announced new contracts for power plant construction in Texas. While 46 hedge fund portfolios held Argan, Inc. (AGX) at the end of Q4, the company is not among the 30 most popular stocks among hedge funds. The Strategy sees potential in AI stocks over Argan, Inc. (AGX). Another article presents a bullish thesis on Argan, Inc. (AGX).

Read more at Yahoo Finance: Here’s What Boosted Argan (AGX) in Q4